- Home
- PHGE vs WETH Comparison
PHGE vs WETH Comparison
Compare PHGE & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- WETH
- Stock Information
- Founded
- PHGE 2015
- WETH 1992
- Country
- PHGE Israel
- WETH China
- Employees
- PHGE N/A
- WETH N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- WETH
- Sector
- PHGE Health Care
- WETH
- Exchange
- PHGE Nasdaq
- WETH Nasdaq
- Market Cap
- PHGE 11.0M
- WETH 10.9M
- IPO Year
- PHGE N/A
- WETH N/A
- Fundamental
- Price
- PHGE $0.42
- WETH $1.00
- Analyst Decision
- PHGE Strong Buy
- WETH
- Analyst Count
- PHGE 1
- WETH 0
- Target Price
- PHGE $15.00
- WETH N/A
- AVG Volume (30 Days)
- PHGE 265.4K
- WETH 51.5K
- Earning Date
- PHGE 08-13-2025
- WETH 08-18-2025
- Dividend Yield
- PHGE N/A
- WETH N/A
- EPS Growth
- PHGE N/A
- WETH N/A
- EPS
- PHGE N/A
- WETH 0.34
- Revenue
- PHGE N/A
- WETH $41,024,264.00
- Revenue This Year
- PHGE N/A
- WETH N/A
- Revenue Next Year
- PHGE N/A
- WETH N/A
- P/E Ratio
- PHGE N/A
- WETH $2.68
- Revenue Growth
- PHGE N/A
- WETH 2.86
- 52 Week Low
- PHGE $0.34
- WETH $0.76
- 52 Week High
- PHGE $3.86
- WETH $3.62
- Technical
- Relative Strength Index (RSI)
- PHGE 39.46
- WETH 50.88
- Support Level
- PHGE $0.42
- WETH $0.90
- Resistance Level
- PHGE $0.47
- WETH $0.99
- Average True Range (ATR)
- PHGE 0.05
- WETH 0.08
- MACD
- PHGE 0.00
- WETH 0.01
- Stochastic Oscillator
- PHGE 47.00
- WETH 60.78
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.